Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVEREST: Everolimus + Cyclosporine in Renal Transplant Extension
NCT01276457Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2006
- Primary completion
- Feb 2009
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of everolimus in renal transplant rejection (RTR), sponsored by Novartis. Started May 2006; status: completed.
02
Drugs
everolimus
03
Conditions
renal transplant rejection (RTR)
Beyond the preview
Go deeper on NCT01276457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01276457.